Advanced Solid Tumor Clinical Trials

782 clinical trials for Advanced Solid Tumor across international registries, including 253 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors — RECRUITING · PHASE1
• First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• Anti-GD2 ADC M3554 in Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of MGC026 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors — RECRUITING · PHASE1
• A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations — RECRUITING · PHASE1
• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) — RECRUITING · PHASE1
• A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE2
• Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors — RECRUITING · PHASE1
• First-in-Human Trial of DS1025a in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours — RECRUITING · PHASE1
• SW-682 in Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• Personalized Neoantigen-pulsed Autologous Dendritic Cell Injections for Malignant Solid Tumors — RECRUITING · NA
• A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab — RECRUITING · PHASE1
• BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors — RECRUITING · PHASE1
• A Clinical Study on TIL for the Treatment of Advanced Solid Tumors — RECRUITING · PHASE1
• A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours — RECRUITING · PHASE1
• A Study of LM-168 Combined With Other Anti-tumor Treatments in Participants With Advanced Solid Tumors — RECRUITING · PHASE2
• Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer — RECRUITING · PHASE1
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies — RECRUITING · PHASE1
• A Study of IDP-001 in Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• SLV-154 Treatment of Advanced Cancers — RECRUITING · PHASE1
• Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies — RECRUITING · PHASE1
• Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors — RECRUITING · PHASE1
• APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST — RECRUITING · PHASE1
• Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers — RECRUITING · PHASE1
• A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas — RECRUITING · PHASE1
• Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Immunotherapy Alone or in Combination With Chemotherapy — RECRUITING · PHASE1
• A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours — RECRUITING · PHASE1
• Evaluation of ICP-B208 in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors — RECRUITING · PHASE1
• A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors — RECRUITING · PHASE1
• A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers — RECRUITING · PHASE1
• Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of PYX-201 in Advanced Solid Tumors — RECRUITING · PHASE1
• A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors — RECRUITING · PHASE1
• IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors — RECRUITING · PHASE1

Refine this search